Brain

Evidence of familial vulnerability for epilepsy and psychosis

Philadelphia, PA, May 2, 2012 – Although the two disorders may seem dissimilar, epilepsy and psychosis are associated. Individuals with epilepsy are more likely to have schizophrenia, and a family history of epilepsy is a risk factor for psychosis. It is not known whether the converse is true, i.e., whether a family history of psychosis is a risk factor for epilepsy.

Sleepiness may affect surgeons' ability to deal with the unexpected

Sleep-deprived surgeons can perform a previously learned task or learn a new task as well as surgeons who are rested, according to Penn State College of Medicine researchers. However, in sleep-deprived surgeons, the brain must work harder, which could lead to problems during unexpected events.

The researchers reached these conclusions using simulations to study the effects of sleepiness on surgeons.

Scientists reveal early diagnostic clues for AD using advanced brain imaging technology

Amsterdam, NL, May 2, 2012 -- Alzheimer's disease (AD) is a major neurodegenerative disorder that affects millions of people worldwide. New and accurate techniques for early diagnosis are critical. Pravat K. Mandal, PhD, and his colleagues have developed a completely non-invasive brain imaging technique to measure specific brain chemical changes. This provides a signature of the early stages of AD from the hippocampal region of the brain. Their work is reported in the Journal of Alzheimer's Disease.

Penn scientists develop large-scale simulation of human blood

PHILADELPHIA — Having a virtual copy of a patient's blood in a computer would be a boon to researchers and doctors. They could examine a simulated heart attack caused by blood clotting in a diseased coronary artery and see if a drug like aspirin would be effective in reducing the size of such a clot.

Research yields new clues to how brain cancer cells migrate and invade

Johns Hopkins researchers have discovered that a protein that transports sodium, potassium and chloride may hold clues to how glioblastoma, the most common and deadliest type of brain cancer, moves and invades nearby healthy brain tissue.

The findings, reported in the journal PLoS Biology, also suggest that a cheap FDA-approved drug already on the market could slow movement of glioblastoma cells, and contain their spread.

Neuro researchers sharpen our understanding of memories

Research yields new clues to how brain cancer cells migrate and invade

Researchers have discovered that a protein that transports sodium, potassium and chloride may hold clues to how glioblastoma, the most common and deadliest type of brain cancer, moves and invades nearby healthy brain tissue. The findings, reported 1 May in the online, open-access journal PLoS Biology, also suggest that a cheap FDA-approved drug already on the market could slow movement of glioblastoma cells.

Dopamine impacts your willingness to work

Slacker or go-getter?

Everyone knows that people vary substantially in how hard they are willing to work, but the origin of these individual differences in the brain remains a mystery.

Delirium mouse model helps researchers understand the condition's causes

A new mouse model of delirium developed by Wellcome Trust researchers has provided an important insight into the mechanisms underlying the condition, bringing together two theories as to its causes. Details of the research are published today in the Journal of Neuroscience.

Delirium is a profound state of mental confusion which can include hallucinations and severe mood swings. According to the Royal College of Psychiatrists, one in ten hospital patients will experience a period of delirium.

Differences in dopamine may determine how hard people work

Washington, DC — Whether someone is a "go-getter" or a "slacker" may depend on individual differences in the brain chemical dopamine, according to new research in the May 2 issue of The Journal of Neuroscience. The findings suggest that dopamine affects cost-benefit analyses.

McLean Report on nanotechnology that may enhance medication delivery and improve MRI performance

Belmont, MA - Researchers at Harvard-affiliated McLean Hospital have shown a new category of "green" nanoparticles comprised of a non-toxic, protein-based nanotechnology that can non-invasively cross the blood brain barrier and is capable of transporting various types of drugs.

Researchers gain better understanding of mechanism behind tau spreading in the brain

Researchers at Mount Sinai School of Medicine have gained insight into the mechanism by which a pathological brain protein called tau contributes to the progression of Alzheimer's disease (AD) and other neurodegenerative disorders. This finding, published in the most recent issue of the Journal of Biological Chemistry, may provide the basis for future investigations on how to prevent tau from damaging brain circuits involved in cognitive function.

National poll: Low cost, lifesaving services missing from most older patients' health care

New York, NY(May 1, 2012) – Large majorities of older Americans experience significant and troubling gaps in their primary care, according to a new national survey, "How Does It Feel? The Older Adult Health Care Experience," released today by the John A. Hartford Foundation, a champion for improved geriatric care and longtime partner of the Hartford Institute for Geriatric Nursing at New York University's College of Nursing.

Blood pressure drugs linked with lower PTSD symptoms

Traumatized people who take a class of common blood pressure medications tend to have less severe post-traumatic stress symptoms, researchers have found.

The finding suggests that ACE (angiotensin converting enzyme) inhibitors or ARBs (angiotensin receptor blockers) could be valuable tools for treating or preventing post-traumatic stress disorder.

The results were published online May 1 in the Journal of Clinical Psychiatry.

Researchers at Hebrew University identify genetic systems disrupted in autistic brain

Jerusalem, April 30, 2012 -- Autism has a strong genetic basis, but so far efforts to identify the responsible genes have had mixed results. The reason for this is that autism is influenced by many different genes, and different genes are involved in different individuals, making it hard to find the common genetic ground between patients.